Wart Treatment
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
54
NCT02338336
A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 28, 2015
Completion: Dec 31, 2015
Loading map...